Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flexion Therapeutics Inc (NASDAQ:FLXN)

26.25
Delayed Data
As of Mar 23
 +6.57 / +33.38%
Today’s Change
8.15
Today|||52-Week Range
28.20
+38.01%
Year-to-Date
Flexion (FLXN) Stock Soars 35% on $1 Billion Sanofi Buyout
Mar 23 / Zacks.com - Paid Partner Content
Sanofi Said to Be Near $1 Billion Deal for Flexion
Mar 23 / TheStreet.com - Paid Partner Content
Health Care Vote Impacts Trump's Deal Maker Image
Mar 23 / TheStreet.com - Paid Partner Content
TPG Group Holdings (SBS) Advisors, Inc. Buys Quintiles IMS Holdings, Cousins Properti...
Mar 17 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close19.68
Today’s open19.69
Day’s range19.59 - 28.20
Volume9,203,715
Average volume (3 months)448,680
Market cap$624.5M
Dividend yield--
Data as of 3:59pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)-32.09%
Earnings growth (this year)-20.46%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.33

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...+0.11+0.81%
ITCIIntra-Cellular Thera...+0.39+2.71%
VNDAVanda Pharmaceutical...+0.15+1.08%
MGNXMacroGenics Inc-0.40-2.19%
Data as of 3:59pm ET, 03/23/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$0.00
Annual profit (last year)-$71.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael D. Clayman
Senior Vice President-
CMC Operations
Dan Leblanc
Corporate headquarters
Burlington, Massachusetts

Forecasts


Search for Jobs